- Home
- GPAT vs NPCE Comparison
GPAT vs NPCE Comparison
Compare GPAT & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPAT
- NPCE
- Stock Information
- Founded
- GPAT 2020
- NPCE 1997
- Country
- GPAT United States
- NPCE United States
- Employees
- GPAT N/A
- NPCE N/A
- Industry
- GPAT
- NPCE Medical Specialities
- Sector
- GPAT
- NPCE Health Care
- Exchange
- GPAT NYSE
- NPCE Nasdaq
- Market Cap
- GPAT 365.5M
- NPCE 424.1M
- IPO Year
- GPAT 2024
- NPCE 2021
- Fundamental
- Price
- GPAT $10.57
- NPCE $10.13
- Analyst Decision
- GPAT
- NPCE Buy
- Analyst Count
- GPAT 0
- NPCE 7
- Target Price
- GPAT N/A
- NPCE $15.14
- AVG Volume (30 Days)
- GPAT 84.6K
- NPCE 402.2K
- Earning Date
- GPAT 01-01-0001
- NPCE 08-12-2025
- Dividend Yield
- GPAT N/A
- NPCE N/A
- EPS Growth
- GPAT N/A
- NPCE N/A
- EPS
- GPAT 0.36
- NPCE N/A
- Revenue
- GPAT N/A
- NPCE $84,306,000.00
- Revenue This Year
- GPAT N/A
- NPCE $21.00
- Revenue Next Year
- GPAT N/A
- NPCE $11.81
- P/E Ratio
- GPAT $29.50
- NPCE N/A
- Revenue Growth
- GPAT N/A
- NPCE 22.05
- 52 Week Low
- GPAT $9.98
- NPCE $5.45
- 52 Week High
- GPAT $10.64
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- GPAT N/A
- NPCE 41.57
- Support Level
- GPAT N/A
- NPCE $9.88
- Resistance Level
- GPAT N/A
- NPCE $11.53
- Average True Range (ATR)
- GPAT 0.00
- NPCE 0.71
- MACD
- GPAT 0.00
- NPCE 0.02
- Stochastic Oscillator
- GPAT 0.00
- NPCE 36.77
About GPAT GP-ACT III ACQUISITION CORP
GP-Act III Acquisition Corp is a blank check company.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.